Loading patent…
AssigneeInnovac Corporation
InventorsTae Wook Hahn, Kashinath Abhijit Barate, Ki Ju Kim, Woo Sung Shin
Estimating the term…
Provided are a recombinant protein for producing a swine Mycoplasma infection-preventing vaccine composition, and a swine Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection-preventing vaccine composition including the recombinant protein. When the recombinant proteins for the vaccine production in accordance with the present disclosure are added to the swine Mycoplasma infection-preventing vaccine composition, the immune response to the swine Mycoplasma hyopneumoniae and swine Mycoplasma hyorhinis strain and the immune response to the P97 protein are increased. As a result, the present vaccine exhibits a defensive effect superior to an existing commercially available vaccine. Therefore, the recombinant proteins for the vaccine production according to the present disclosure and the vaccine compositions using the recombinant proteins may effectively prevent diseases caused by the Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection, especially, swine Mycoplasma-derived pneumonia and swine Mycoplasma-derived arthritis.
A recombinant protein for production of vaccine for prevention of swine Mycoplasma hyopneumoniae infection, the protein comprising an amino acid sequence represented by SEQ ID NO.:
A method for producing a Mycoplasma hyopneumoniae infection-preventing vaccine adjuvant, the method comprising:
A recombinant protein for production of a vaccine for prevention of swine Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection, the protein comprising an amino acid sequence represented by SEQ ID NO.:
A method for producing a swine Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection-preventing vaccine adjuvant, the method comprising:
Dependencies are inferred from the claim text.